Your browser doesn't support javascript.
loading
Inactivating NF1 Mutations Are Enriched in Advanced Breast Cancer and Contribute to Endocrine Therapy Resistance.
Pearson, Alex; Proszek, Paula; Pascual, Javier; Fribbens, Charlotte; Shamsher, Monee K; Kingston, Belinda; O'Leary, Ben; Herrera-Abreu, Maria T; Cutts, Rosalind J; Garcia-Murillas, Isaac; Bye, Hannah; Walker, Brian A; Gonzalez De Castro, David; Yuan, Lina; Jamal, Sabri; Hubank, Mike; Lopez-Knowles, Elena; Schuster, Eugene F; Dowsett, Mitch; Osin, Peter; Nerurkar, Ashutosh; Parton, Marina; Okines, Alicia F C; Johnston, Stephen R D; Ring, Alistair; Turner, Nicholas C.
Afiliação
  • Pearson A; Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, United Kingdom.
  • Proszek P; The Centre for Molecular Pathology, The Royal Marsden Hospital, Sutton, Surrey, United Kingdom.
  • Pascual J; Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, United Kingdom.
  • Fribbens C; Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, United Kingdom.
  • Shamsher MK; Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, United Kingdom.
  • Kingston B; Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, United Kingdom.
  • O'Leary B; Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, United Kingdom.
  • Herrera-Abreu MT; Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, United Kingdom.
  • Cutts RJ; Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, United Kingdom.
  • Garcia-Murillas I; Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, United Kingdom.
  • Bye H; The Centre for Molecular Pathology, The Royal Marsden Hospital, Sutton, Surrey, United Kingdom.
  • Walker BA; The Centre for Molecular Pathology, The Royal Marsden Hospital, Sutton, Surrey, United Kingdom.
  • Gonzalez De Castro D; The Centre for Molecular Pathology, The Royal Marsden Hospital, Sutton, Surrey, United Kingdom.
  • Yuan L; The Centre for Molecular Pathology, The Royal Marsden Hospital, Sutton, Surrey, United Kingdom.
  • Jamal S; The Centre for Molecular Pathology, The Royal Marsden Hospital, Sutton, Surrey, United Kingdom.
  • Hubank M; The Centre for Molecular Pathology, The Royal Marsden Hospital, Sutton, Surrey, United Kingdom.
  • Lopez-Knowles E; Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, United Kingdom.
  • Schuster EF; Ralph Lauren Centre for Breast Cancer Research, Royal Marsden Hospital, London, United Kingdom.
  • Dowsett M; Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, United Kingdom.
  • Osin P; Ralph Lauren Centre for Breast Cancer Research, Royal Marsden Hospital, London, United Kingdom.
  • Nerurkar A; Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, United Kingdom.
  • Parton M; Ralph Lauren Centre for Breast Cancer Research, Royal Marsden Hospital, London, United Kingdom.
  • Okines AFC; Breast Unit, The Royal Marsden Hospital, London, United Kingdom.
  • Johnston SRD; Breast Unit, The Royal Marsden Hospital, London, United Kingdom.
  • Ring A; Breast Unit, The Royal Marsden Hospital, London, United Kingdom.
  • Turner NC; Breast Unit, The Royal Marsden Hospital, London, United Kingdom.
Clin Cancer Res ; 26(3): 608-622, 2020 02 01.
Article em En | MEDLINE | ID: mdl-31591187
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Resistencia a Medicamentos Antineoplásicos / Ciclina D1 / Neurofibromina 1 / Mutação Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Female / Humans / Middle aged Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Resistencia a Medicamentos Antineoplásicos / Ciclina D1 / Neurofibromina 1 / Mutação Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Female / Humans / Middle aged Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Reino Unido